Invesco Ltd. Icosavax, Inc. Call Options Transaction History
Invesco Ltd.
- $460 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ICVX
# of Institutions
2Shares Held
1.37MCall Options Held
0Put Options Held
0About Icosavax, Inc.
- Ticker ICVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,885,200
- Description
- Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...